Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00130481 · ClinicalTrials.gov registry record · NA
Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT00130481 is a NA study that has completed, run by University of Florida. The registered enrollment target is 100 participants.
The verdict
NCT00130481, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Atorvastatin can improve blood vessel stiffness and blood vessel function in children 10-18 years old with Type 1 and Type 2 diabetes. Subjects will receive atorvastatin 20mg or placebo daily for 3 months and will then switch therapies for the next 3 months. Hypothesis: Atorvastatin will improve blood vessel function by decreasing arterial stiffness and improving blood flow.
Interventions
- DRUG Atorvastatin 20 mg daily for 3 months
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2005-04 |
| Est. Completion | 2007-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00130481
The ClinicalTrials.gov registry entry for NCT00130481 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Atorvastatin 20 mg daily for 3 months is the first listed.
NCT00130481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00130481 about?
NCT00130481 is a clinical study titled "Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)". The purpose of this study is to determine if Atorvastatin can improve blood vessel stiffness and blood vessel function in children 10-18 years old with Type 1 and Type 2 diabetes. Subjects will receive atorvastatin 20mg or placebo daily for 3 months and will then switch therapies for the next 3 mont...
What is the current status of trial NCT00130481?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2005-04. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00130481?
The interventions under investigation include: Atorvastatin 20 mg daily for 3 months (DRUG).
Who is sponsoring clinical trial NCT00130481?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.